Myfortic 360 mg gastro-resistant tablets are crucial in the field of transplant medicine, particularly for patients undergoing kidney transplants. These tablets contain mycophenolic acid, an immunosuppressant that plays a vital role in preventing organ rejection.
This article aims to provide a comprehensive overview of Myfortic 360 mg gastro-resistant tablets, including their uses, side effects, dosing guidelines, and alternatives. Understanding these aspects is essential for patients and healthcare professionals alike.
What are Myfortic 360 mg gastro-resistant tablets?
Myfortic 360 mg gastro-resistant tablets are specifically formulated to release mycophenolic acid in the gastrointestinal tract. This unique formulation helps to minimize gastrointestinal side effects, making it easier for patients to adhere to their treatment regimens.
Produced by Novartis, Myfortic is primarily prescribed to prevent acute rejection in kidney transplant recipients. Myfortic 360 mg gastro-resistant tablets are part of a comprehensive immunosuppressive therapy that often includes other agents.
These tablets are available in two dosages: 180 mg and 360 mg. The recommended dose is typically 720 mg per day, divided into two doses of 360 mg each. This dosing schedule allows for optimal therapeutic effects while minimizing potential side effects.
What are the uses of Myfortic 360 mg?
Myfortic 360 mg is primarily used as an immunosuppressant to prevent kidney transplant rejection. It is instrumental in maintaining the functionality of the transplanted organ by suppressing the immune response.
Beyond kidney transplants, Myfortic may have off-label uses in treating certain autoimmune conditions, although these applications are less common. It is essential that patients only use Myfortic under the supervision of a healthcare provider.
- Prevention of kidney transplant rejection
- Potential off-label uses in autoimmune diseases
- Part of a multi-agent immunosuppressive regimen
How much is Myfortic 360 mg?
The price of Myfortic 360 mg can vary based on several factors, including the pharmacy, insurance coverage, and location. It is considered a prescription medication, so prices may differ significantly.
On average, the retail price for Myfortic 360 mg can range from $500 to $1,000 per month. Many patients may find financial assistance programs or generic alternatives beneficial for reducing costs.
It is advisable for patients to consult with their pharmacists or healthcare providers to obtain the most accurate pricing information and explore potential financial options.
What are the side effects of Myfortic 360 mg?
Like any medication, Myfortic 360 mg can cause side effects. Common side effects include gastrointestinal disturbances such as diarrhea, nausea, and vomiting.
Other serious risks associated with Myfortic include an increased susceptibility to infections and potential malignancies due to its immunosuppressive action. Patients are advised to be vigilant about any unusual symptoms and report them to their healthcare provider promptly.
- Gastrointestinal issues (nausea, vomiting, diarrhea)
- Increased risk of infections
- Potential for malignancies
- Blood disorders (anemia, leukopenia)
How do you take Myfortic 360 mg?
Myfortic 360 mg should be taken as prescribed by a healthcare provider. It is recommended to take the tablets with water, preferably on an empty stomach, to enhance absorption.
The usual dosing regimen involves taking 360 mg twice daily, ideally at the same times each day to maintain consistent blood levels of the medication. Patients should never adjust their dosages without consulting their healthcare provider.
It’s crucial to follow the Patient Information Leaflet (PIL) that accompanies the medication, as it provides essential safety information and dosing recommendations.
What alternatives are available to Myfortic 360?
There are several alternatives to Myfortic 360 mg that are also used in immunosuppressive therapy. One of the most notable is CellCept, which contains the same active ingredient—mycophenolate mofetil.
Other alternatives may include different classes of immunosuppressants, such as corticosteroids and calcineurin inhibitors, which can be used in conjunction with or instead of Myfortic, depending on the patient’s needs.
- CellCept (mycophenolate mofetil)
- Azathioprine
- Corticosteroids (prednisone)
- Calcineurin inhibitors (tacrolimus, cyclosporine)
How does Myfortic 360 compare to CellCept?
Myfortic and CellCept are both forms of mycophenolate, but they differ in formulation and absorption. Myfortic is the gastro-resistant form, designed to minimize gastrointestinal side effects.
CellCept, on the other hand, is available as a tablet or oral suspension and is often associated with a higher incidence of gastrointestinal side effects. However, some patients may respond better to one formulation over the other.
In terms of efficacy, both medications have been shown to be effective in preventing transplant rejection. The choice between Myfortic and CellCept generally depends on individual patient tolerance and physician recommendations.
Related questions about Myfortic 360 mg
What is Myfortic 360 mg used for?
Myfortic 360 mg is primarily used to prevent acute rejection in patients who have undergone kidney transplants. It is vital in immunosuppressive therapy, enhancing the chances of transplant success. It is also crucial for patients to follow their healthcare provider’s instructions closely to optimize treatment outcomes.
What is the difference between Myfortic and mycophenolate?
Myfortic is a specific formulation of mycophenolic acid designed to be gastro-resistant, while mycophenolate refers broadly to the class of medications that includes both Myfortic and CellCept. Both serve similar purposes in preventing organ rejection, but Myfortic’s gastro-resistant properties may benefit patients experiencing gastrointestinal issues.
What are the active ingredients in Myfortic?
The active ingredient in Myfortic 360 mg gastro-resistant tablets is mycophenolic acid. This component is responsible for the medication’s immunosuppressive effects, playing a critical role in preventing the body from rejecting transplanted organs.
What are the ingredients in mycophenolic acid 360 mg?
In addition to mycophenolic acid, Myfortic 360 mg contains several inactive ingredients that help in the tablet’s formulation, including excipients used for stability and absorption. Patients should consult the Patient Information Leaflet for a comprehensive list of all ingredients.